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Abstract 
Acetylsalicylic acid (trade name Aspirin) is a well-known drug with antipyretic and analgesic 
effects. Mixtures that benefit from better solubility of its sodium salt have been sold for 
almost 90 years. Currently, several drug products are available with sodium aspirin as their 
active ingredient, but, until now, its crystal structure remained unknown. We have 
investigated the multicomponent system of sodium acetylsalicylate with the following results: 
an anhydrate and a dihydrate of a 1:1 salt were identified together with a hemihydrate of a 2:1 
salt. Crystal structures of all forms were solved by single-crystal X-ray diffraction. The 
structural changes upon desolvation were studied by simultaneous TG/DSC supported by X-
ray powder diffraction. The crystal structures were compared to those of all up-to-date 
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Abstract 
Acetylsalicylic acid (trade name Aspirin) is a well-known drug with antipyretic and analgesic 
effects. Mixtures that benefit from better solubility of its sodium salt have been sold for 
almost 90 years. Currently, several drug products are available with sodium aspirin as their 
active ingredient, but, until now, its crystal structure remained unknown. We have 
investigated the multicomponent system of sodium acetylsalicylate with the following results: 
an anhydrate and a dihydrate of a 1:1 salt were identified together with a hemihydrate of a 2:1 
salt. Crystal structures of all forms were solved by single-crystal X-ray diffraction. The 
structural changes upon desolvation were studied by simultaneous TG/DSC supported by X-
ray powder diffraction. The crystal structures were compared to those of all up-to-date 
published crystal structures of aspirin salts. Both of the hydrated sodium salts belong to the 
same isostructural family, while the anhydrate crystallizes with a unique packing of the 
acetylsalicylate anions. 
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Acetylsalicylic acid (ASA) has enjoyed the popularity of patients for more than 115 years1 as 
the drug product Aspirin®. It belongs to the group of the first-choice drugs. The therapeutic 
use of acetylsalicylic acid is still widening today. In the beginnings, ASA was administered 
as an analgesic and antipyretic drug with lower side effects than its predecessor salicylic 
acid2. Other uses of ASA connected to its ability to decrease blood clotting were discovered 
as well. That resulted in the administration of aspirin in prevention and treatment of 
cardiovascular diseases, heart attacks and strokes.3 Nowadays, many scientists are looking for 
new connections between regular use of acetylsalicylic acid and decreasing risk of cancer, 
Alzheimer's disease or diabetes.4–6  
ASA is poorly soluble at the conditions of stomach juice, as the low pH in the stomach 
impedes the dissolution of ASA. Poor solubility of the drug causes aggregation of insoluble 
particles in the stomach. These insoluble aggregates promote damage to the gastric mucosa, 
which lead to side effects such as gastritis and peptic ulcers.7  
One option how to improve drugs solubility is through crystal engineering. The solid state 
chemistry is a very important aspect in the pharmaceutical development. Solid forms, such as 
polymorphs, solvates, salts or co-crystals can modify the physicochemical and resultant 
biological properties such as solubility, permeability, hygroscopicity, stability, dissolution 
profile and bioavailability of a drug without any changes in its chemical structure8,9. Salt 
formation (salification) belongs to popular approaches in pharmaceutical development.10–13 
About 50 % of all drugs are used as salts9. Many of the new drugs are poorly soluble in water 
and salification can be an elegant solution for ionizable compounds. Ionizable compounds 
contain acidic or basic function groups, to which suitable counterions can be bound.14  
In the literature, we can find that ASA forms many salts with inorganic or organic partners. In 
the CSD15, there are 27 unique crystal structures of ASA salts and metallic complexes with 
Cu, K, Zn, Bi, Ca, Cd, Sn, Ag, Hg, Ni, Li, Ru, Pb, Rb and organic cations. It is worth noting, 
that some of these structures contain other molecules in addition to ASA and the cation. The 
full list of these structures can be found in the Figure S1 in SI. 
Other ASA salts, for which the crystal structure has not been described, exist as well. Some 
of them contain the pharmaceutically acceptable partners (e.g. Al, D,L-lysine) and are 
successfully marketed. For example, the salt with D,L-lysine is known under the trade name 
Alcacyl® 500 Instant-Pulver or Aspégic®. In this work, we have focused on the Na salt16, 
which is the active ingredient in drug products such as Alka-Seltzer®, Catalgine®, 
TABCIN®, Vida Mia®, Zee-Seltzer®.17–19 
Even though the sodium acetylsalicylate (sodium aspirin, ASNa) has been known and used 
by patients for a very long time period20 (Alka-Seltzer has been on the market since 193121), 
the crystal structure remained unknown. Therefore, we have focused on the preparation of its 
diffraction-quality single-crystals and we have been successful in preparation of three forms 
of this salt and in solving all of their crystal structures. 
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2 Experimental section 
2.1 Materials 
Acetylsalicylic acid was purchased from Sigma-Aldrich (purity >99%). Sodium bicarbonate 
(purity >99%) and propan-2-ol (purity >99.8%) were obtained from Penta. 
2.2 General Salt Preparation Route 
The general principle of the aspirin sodium salt synthesis is based on careful neutralization of 
ASA. Suitable neutralization agents can be weak bases e.g. carbonates or bicarbonates 
(Scheme 1a). Unlike for the potassium aspirin salt, using strong basis is inappropriate, 
because the formed salt hydrolyses in basic environment (Scheme 1b).  
First, we have attempted the reproduction of ASNa preparation according to available 
patents20, but with limited success only. Therefore, we optimized parameters like amount of 
water, combination of water and solvent for initiating the reaction and the conditions of the 
crystallization. Our optimized preparation process is as follows: ASA is reacted with sodium 
bicarbonate in the presence of a small amount of water that initiates the reaction. Additional 
water is produced as a side product, which keeps the reaction running. The end of the reaction 
is indicated by the extinction of the CO2 bubbles. Then, propan-2-ol is added and the solution 
is filtered. The crystallization of the individual forms depends on the different crystallization 
conditions. 
It is worth noting that we observed that the success rate and the yield of our experiments 
improved over time, even for the experiments with seemingly identical procedures and 
conditions. This lead us to believe that, for the successful crystallization of sodium aspirin, 
the ‘contamination’ of the environment with its crystallization nuclei22 is essential. 
 
Scheme 1. a) The ASNa salt preparation route, b) hydrolysis of the salt 
2.3 Preparation of the Solid Forms. 
Single crystals of ASNa dihydrate were prepared by mixing ASA with small amount of 
water, and, then, sodium bicarbonate was added. The mixture immediately began to react. 
After the reaction, which took about 20 hours, propan-2-ol was poured into the reaction 
mixture, which was filtered subsequently. The pure solution was stored in a freezer. 
Plate-like crystals were grown within a few hours. 
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Crystals of ASNa anhydrate were successfully prepared in two ways - direct synthetic route 
and by the dehydration of the dihydrate form. 1) ASA was mixed with small amount of water 
and sodium bicarbonate. The mixture was left to react for approximately 20 hours and then 
cold propan-2-ol was added. The solution was filtered and allowed to crystallize under 
reduced pressure in a vacuum oven at room temperature. A static vacuum was applied. The 
starting pressure level was 0.3 kPa, slowly increasing to 5 kPa. 2) ASNa dihydrate, prepared 
according to the process above, was dehydrated in vacuum drying oven. The dehydration was 
carried out under reduced pressure (about 0,1 kPa) during about 36 hours. A powder material 
suitable for XRPD was prepared this way. 
A hemihydrate of the 2:1 salt was prepared using a mixture of water and propan-2-ol (2:1 
v/v) to initiate the reaction between ASA and sodium bicarbonate. Crystals were obtained 
after the end of the reaction. No additional solvent was added. 
2.4 Differential Scanning Calorimetry/Thermogravimetric Analysis 
(DSC/TG). 
A combined analysis of DSC/TG was measured on a simultaneous thermoanalyser TG-DSC 
Sensys Evo. The device is equipped with a Calvet 3D sensor. Samples were measured in air 
atmosphere. The temperature range was 20 - 300 °C with the heating rate of 10 °C/min. The 
samples were measured in non-hermetically sealed Al pans.  
2.5 Powder X-Ray Diffraction (PXRD). 
For preliminary analysis a X'Pert3 Powder PANalytical diffractometer with CuKα1,2 radiation 
(wavelength 1.54180 Å) was used at 40 kV and 30 mA.  The samples were measured on the 
silicon wafer and scanned within a range of 5.013 - 39.983° 2Θ with a step size of 0.026° 2Θ 
and a step time of 21.32 s. The evaluation of samples was done by the software HighScore 
Plus23. 
2.6 Single Crystal X-Ray Diffraction (SXRD). 
ASNa anhydrate crystallized as colourless needles. Quality crystals were obtained from the 
mother liquor, directly mounted to the goniometer head and cooled down. The analyses were 
conducted using the four-circle RTG diffractometer Bruker D8 Venture. The diffractometer is 
equipped with Incoatec IµS micro-focus source (high brilliance multilayer optics), CuKα 
radiation with the wavelength of 1.5418 Å, and CMOS detector Photon 100. Data collection, 
unit cell refinement and data reduction was done by Bruker SAINT software24. Single 
crystals of ASNa dihydrate were crystallized from propan-2-ol and of ASNa hemihydrate 
from propan-2-ol : water (1:2 v/v). CuKα diffraction data of both crystals were collected on 
four-circle RTG diffractometer Xcalibur PX. Data collection, unit cell refinement and data 
reduction was done by CrysAlisPro CCD.25 Twin laws in all structures were searched for by 
ROTAX26 and no twinning was found. All structures were solved by direct methods by 
Sir9227. Program CRYSTALS28 was used to refine structure and analyze absolute 
configuration. The positional and anisotropic thermal parameters of all non-hydrogen atoms 
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were refined. The hydrogen atoms were located in a Fourier difference map and refined 
riding with their pivot atoms. Molecular graphics were prepared in Mercury29 and Discovery 
Studio.30 
3 Results and Discussion 
By a crystallization of acetylsalicylic acid with sodium bicarbonate, three crystalline forms of 
a sodium salt were prepared and their structures were solved. They included the anhydrate 
and the dihydrate of sodium acetylsalicylate (ASNa) and the hemihydrate of the 2:1 salt.  
All structures were solved by single-crystal diffraction. The data collection and refinement 
details are described in Table 1. Distances and angles between Na and carboxylic oxygen 
atoms can be found in Table S1 in Supporting information. 
 
 Table 1. Crystallographic data of the sodium acetylsalicylate forms 
Form ASNa anhydrate ASNa dihydrate ASNa 2:1 hemihydrate  
Empirical formula C9 H7 Na1 O4 C9 H11 Na1 O6 C9 H8.5 Na0.5 O4.5 
Formula weight 202.14 238.17 200.16 
Crystallographic system trigonal monoclinic monoclinic 
Space group R 3c P 21/c C 2/c 
a (Å) 39.7168(13)  15.2144(3) 25.3326(17) 
b (Å) 39.7168(13)  6.86391(14) 7.8837(6) 
c (Å) 6.0865(2)  10.4770(3) 10.6356(8) 
α (°) 90 90 90 
β (°) 90 104.639(2) 109.174(6) 
γ (°) 120 90 90 
V (Å3) 8314.7(3)  1058.60(3) 2005.46(15) 
Z, calculated density (g/cm3) 36, 1.450  4, 1.494 8, 1.326 
F(000) 3726 496 832 
Robs /Rall 0.0841/0.0843 0.0404/0.0437 0.0462/0.0621 
w Robs / w Rall 0.2280/0.2284 0.1115/0.1130 0.0886/0.1074 
Radiation Cu Kα Cu Kα Cu Kα 
Wavelength 1.54184 Å 1.54184 Å 1.54184 Å 
Temperature 180 K 180 K 293 K 
Crystal size (mm) 0.058 x 0.136 x 
0.452 
0.214 x 0.480 x 
0.530 
0.095 x 0.313 x 0.475  
No. of measured reflections 22386 19996 13348 
Independent reflections (Rint) 3365 (0.032) 2199 (0.051) 1799 (0.047) 
Data/parameters 3362/254 2198/158 1799/162 
GoF 0.9420 1.0000 0.9637 
Res. el. dens. (e Å−3) -0.67, 0.91  -0.24, 0.22   -0.20, 0.20  
CCDC No 1840789 1840790 1840788 
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3.1 ASNa anhydrate 
ASNa anhydrate crystallizes in the trigonal system with the R 3c space group, which is rather 
unusual for organic crystals (0.08 % in CSD15). Two molecules of acetylsalicylate and two 
sodium cations are present in the asymmetric unit (Figure 1a). The unit cell then contains 36 
of each species (Figure 1b). The structure is made up of sodium ion channels, onto which the 
acetylsalicylate ions are bound. The channels run along the c-axis direction (Figure 1c). Four 
molecules of acetylsalicylate are bonded to each sodium ion. There are no classical H-bonds 
in the molecular packing. All Na-O bond distances shorter than 2.5 Å and the corresponding 
angles for ASNa anhydrate are shown in Table S1 in Supporting information. The 
comparison of the bond distances reveals that the bond distances are considerably shorter in 
the ASNa anhydrate than in the other two structures. Also, the variation of the values is 
small, which well corresponds with the higher stability of this form. The Na1 and Na11 
surroundings differ significantly. Na11 is coordinated with 5 oxygen atoms, while there are 
only four O atoms in the closer vicinity of Na1.  
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Figure 1. The crystal structure of sodium acetylsalicylate anhydrate; a) the asymmetric unit, 
b) the unit cell, c) a detailed view of the sodium channel surrounded with acetylsalicylate 
ions. Sodium cations displayed in magenta. 
 
The purity of the prepared bulk material was confirmed by XRPD. When the experimental 
diffractogram is compared to the theoretical one, they correspond very well (Figure 2). 
 
Figure 2. Comparison of the experimental (red) and calculated (blue) XRPD of ASNa 
anhydrate 
 
The thermal analysis of sodium acetylsalicylate anhydrate (Figure 3) revealed that it melts at 
229 °C, which is significantly higher than acetylsalicylic acid (180 °C 31). At 237 °C, the 
sample started to oxidatively decompose. Similarly to acetylsalicylic acid, ASNa anhydrate 
slowly decomposes throughout the whole thermal analysis. It experiences a continual 
elimination of the acetic anhydride, which is evidenced by the decreasing mass of the sample 
measured by TG. 
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Figure 3. The thermal analysis (TG/DSC) of sodium acetylsalicylate anhydrate 
 
Table 2. The thermal phenomena of sodium acetylsalicylate anhydrate 
Temp. range DSC TG Explanation 
25-215°C - -3% Slow deacetylation 
215-237°C endothermic 
peak at 229°C 
-4% Melting of anhydrate of 
ASNa; deacetylation 
237-300°C exothermic -36% Oxidative decomposition 
3.2 ASNa dihydrate 
ASNa dihydrate crystallizes in the monoclinic system with the P 21/c space group. In the 
asymmetric unit, it contains a molecule of acetylsalicylate, a sodium cation and two 
molecules of water (Figure 4a). The unit cell contains four ASNa and eight molecules of 
water (Figure 4b). The crystal packing consists of hydrophobic and hydrophilic layers (Figure 
4c). The hydrophobic layers are stabilized by π-π interactions with the benzene rings in the 
herringbone packing32,33. In the hydrophobic layers, the sodium ion is bonded by the Van der 
Waals interactions to two water molecules and to three different molecules of 
acetylsalicylate. Each water molecule donates two H-bonds, one to the aspirin carboxylate 
and one to another water molecule. All Na-O bond distances shorter than 2.5 Å and the 
corresponding angles for ASNa dihydrate are shown in Table S2 in Supporting information. 
The ASNa dihydrate has the longest average distance of Na-O of all the ASNa forms. 
However, it exhibits the highest calculated density value. The distances of the carboxyl 
oxygen atoms and the water molecules to the Na1 cation are very similar. 
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Figure 4. The crystal structure of sodium acetylsalicylate dihydrate; a) the asymmetric unit, 
b) the unit cell, c) the hydrophilic layers containing the sodium cations. Sodium cations 
displayed in magenta. 
 
To complement the crystallographic investigation, the desolvation behaviour was studied by 
the thermal methods. For the TG/DSC analysis, the sample of ASNa dihydrate had to be 
measured wet, because it was too unstable on air. Even then, the measurement was 
accompanied by decomposition (deacetylation). The crystal water constitutes approximately 
15 % of molecular weight of ASNa dihydrate. It leaves the structure in a range of 55 - 125 
°C, see Figure 5. In this range, the sample recrystallizes to ASNa anhydrate and also partially 
decomposes to sodium salicylate. This was verified by XRPD of the sample after TG/DSC to 
130 °C, see Figure 6. After that, the sample is still slowly decomposing and, at 228 °C, the 
formed ASNa anhydrate melts. The phenomena accompanying the thermal analysis are 
explained in detail in Table 3.  
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Figure 5. The thermal analysis (TG/DSC) of sodium acetylsalicylate dihydrate 
 
Table 3. The thermal phenomena of sodium acetylsalicylate dihydrate 
Temp. range DSC TG Explanation 
25-55°C endothermic -5% Evaporation of the free and adsorbed water and the 
beginning of deacetylation 
55-125°C endothermic -18% Dehydration of crystal water; deacetylation; 
recrystallization 
125-220°C - -2% Slow deacetylation 
220-235°C endothermic  
peak at 228°C 
-2% Melting of the anhydrate of ASNa; decomposition 
235-300°C exothermic -20% Oxidative decomposition 
 
 
Figure 6. XRPD of ASNa dihydrate sample after dehydration during TG/DSC up to 130 °C 
(top); ASNa anhydrate (middle); sodium salicylate (bottom). 
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The inclusion of the water molecules in the crystalline structure is probably the cause of the 
high instability of this solid form, because it can readily catalyse the hydrolysis leading to the 
deacetylation (Scheme 1). This instability is the reason that other analyses routinely used to 
study pharmaceutical hydrates, such as DVS, critical water activity determination or variable 
humidity XRPD, could not be performed. 
3.3 ASNa 2:1 hemihydrate 
AsNa 2:1 hemihydrate crystallizes in the monoclinic system with the C 2/c space group. In 
the asymmetric unit, it contains a molecule of acetylsalicylate, a half of a sodium cation and a 
half of a water molecule (Figure 7a). Sodium ions and water oxygen atoms lie on twofold 
rotation axis and the carboxyl hydrogens are placed midway between two acetylsalicylate 
molecules on the centre of symmetry (Figure 7b). This means that each of the acetylsalicylate 
anions has a formal charge of -½ and that the unit cell contains eight molecules of AS, four 
sodium cations and four molecules of water (Figure 7c). 
The crystal packing consists of infinite chains of alternating sodium ions and AS anions that 
run along the c-axis (Figure 8a). Each sodium ion is bonded to four molecules of 
acetylsalicylate and one molecule of water. Water molecules form three-centred H-bonds that 
crosslink the individual chains (Figure 8b). All Na-O bond distances shorter than 2.5 Å and 
the corresponding angles for ASNa 2:1 hemihydrate are shown in Table S3 in Supporting 
information. As could be expected, the highly unstable structure of ASNa – hemihydrate 
exhibits the lowest density. There is one remarkably short bond (2.210(5) Å) between Na1 
and water O6, which occupies a 2-fold axis. The special position arrangement is reflected by 
the symmetry of the rest Na-O bonds, which cluster in pairs sharing equal distances and 
angles.  
The preparation of this form in larger quantity necessary for further analysis was not 
successful.  
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Figure 7. The crystal structure of ASNa 2:1 hemihydrate; a) the asymmetric unit, b) the 
special positions c) the unit cell, d) the hydrophilic layers containing the sodium cations. 
Sodium cations displayed in magenta. 
 
 
Figure 8. a) the chains of alternating sodium and acetylsalicylate ions in ASNa 2:1 
hemihydrate; b) water molecule connecting the parallel chains by H-bonding. Sodium cations 
displayed in magenta. 
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3.4 Structural Comparison 
The three novel sodium salts were compared to all 27 up-to-date published structures of 
acetylsalicylate salts. Both the conformation of the AS anion and their molecular packing 
were studied using CrystalCMP34 software. 
The similarities and differences in the molecular packing were analyzed employing a packing 
similarity tree diagram. The tree diagram is used for a clear analysis of similarity in the 
crystal packing of a group of structures. It can compare the crystal packing of chosen 
molecules or fragments of the structure.  Therefore, it can be easily used to analyze a family 
of polymorphs, hydrates, solvates, salts and co-crystals. During the calculation, the clusters of 
10 molecules are generated for each form and all clusters are compared to each other. The 
similarity is calculated on the bases of the distance and rotation of the respective molecules. 
Figure S1 in SI shows the diagram for all of the 30 AS salts, while Figure 9 shows only those 
published here and those forming isostructural families. 
From the packing similarity dendrogram, we can identify three distinct ‘isostructural’ 
families. Out of the 30 crystal structures included in the calculation, 19 do not belong to any 
‘isostructural’ family (meaning that the crystal packing of their AS ions is unique). 
The largest isostructural family contains seven structures, while the other two only contain 
two structures each. The smaller families are both formed from Cu salts. The larger family 
contains ASNa dihydrate and ASNa 2:1 hemihydrate. It also contains the first ever described 
structure of an aspirin salt with benzamidine.35 It was found that ASNa 2:1 is highly similar 
to the 2:1 salt with potassium (Figure 10). ASNa anhydrate is one of the structures that do not 
belong to any isostructural family. 
 
 
Figure 9. Packing similarity tree diagram of different AS salts. AS Na salts highlighted. Only 
AS molecules considered. A part of the figure between 18 and 48 has been deleted, to make 
the figure shorter and more readable - this deletion is indicated by the curved line. Only the 
structures belonging to isostructural families shown - please see the SI for the figure with all 
known AS salts. Calculated by CrystalCMP34. 
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Figure 10. Similar molecular packing of the acetylsalicylate anions in 2:1 sodium and 
potassium salts; ASNa 2:1 hemihydrate (red) and KHDASL01 (violet). Calculated by 
CrystalCMP34. 
 
Another calculation in CrystalCMP34 was performed to sort the structures based on their AS 
conformation. To do this, the number of neighbouring molecules was set to 0 and the 
inversion test was enabled. From Figure S2 in SI, we can identify that AS salts crystallize 
with seven distinct conformations of the AS anion. The overlay of these conformations is 
shown in Figure 11. Variability was observed in both of the flexible regions of the AS 
molecule (the rotation of the carboxylate and the torsion of the ester side chain). 
  
Figure 11. Conformational variability of acetylsalicylate in the various crystal structures. 
Only representative structures are shown for each group identified by CrystalCMP34: 
ASNa anhydrate dark green; ASNa dihydrate pink; ASNa 2:1 hemihydrate sea-foam; 
AMALEG light green; SEYHOV blue; IVUYEE red; FEHGAB black. 
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After long 87 years since the first drug product containing this compound was introduced to 
the market we report the crystallization and structural characterization of the sodium salts of 
acetylsalicylic acid (sodium aspirin). Although several products are available with sodium 
aspirin as their active ingredient, its crystal structure remained unknown until today. 
Anhydrate and dihydrate forms of the 1:1 sodium aspirin salt were prepared. Together with 
the crystal structure solution, the forms were characterized by thermal analysis and a complex 
decomposition pathway of the dihydrate was discovered. Additionally, the crystal structure of 
the novel 2:1 sodium salt was solved as a hemihydrate. The crystal structures were compared 
to all up-to-date published crystal structures of aspirin salts with regard to the conformation 
of the acetylsalicylate anion and its molecular packing. It was observed, that, only three 
isostructural families exist among the 30 structures, while two thirds of the salts crystallize 
with a unique packing of the acetylsalicylate anions. 
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Currently, several drug products are available with sodium aspirin as their active ingredient, 
but, until now, its crystal structure remained unknown. We have investigated the 
multicomponent system of sodium acetylsalicylate with the following results: an anhydrate 
and a dihydrate of a 1:1 salt were identified together with a hemihydrate of a 2:1 salt. Both of 
the hydrated sodium salts belong to the same isostructural family, while the anhydrate 
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